The Core Issue: Failure to Warn Patients of Severe Risks The central argument in the GLP-1 lawsuits is that manufacturers like Novo Nordisk and Eli Lilly knew, or should have known, about the risk of severe side effects like stomach paralysis and bowel obstruction but failed to adequately warn doctors and patients
Half of my practice is caring for patients under 55, a shift from when people would wait years for treatment
At Surest, we recognize that not all doctors and facilities are the same
Based on 125,474 adults with overweight or obesity who newly initiated GLP-1based injectables between January 1, 2018 and December 31, 2023
Obstructive sleep apnea is primarily due to obesity, so if they are able to maintain the weight loss, they will keep the beneficial effects resolving sleep apnea, and improving diabetes and high blood pressure, etc, said Ali, who was not involved in the new research